beta

AGLE

Aeglea BioTherapeutics Inc.

Agle

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.

Market Cap: 111 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.aegleabio.com

Shares Outstanding: 16.6 Million

Float: 16.2 Million

Dividend: 0.0 (0.0%)

Beta: 0.0

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 38.4 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1403 trading days

From: 2016-04-08 To: 2019-10-18

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud